196 related articles for article (PubMed ID: 4142544)
1. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.
Springer GF; Desai PR
Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544
[TBL] [Abstract][Full Text] [Related]
2. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
Cooper AG; Codington JF; Miller DK; Brown MC
J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
[TBL] [Abstract][Full Text] [Related]
3. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
Miller SC; Codington JF; Klein G
J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
[TBL] [Abstract][Full Text] [Related]
5. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
Fung PY; Longenecker BM
Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
[TBL] [Abstract][Full Text] [Related]
6. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
8. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
9. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.
Springer GF; Desai PR; Banatwala I
J Natl Cancer Inst; 1975 Feb; 54(2):335-9. PubMed ID: 163330
[TBL] [Abstract][Full Text] [Related]
10. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
11. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of Vicia graminea lectin- and Vicia unijuga lectin-binding glycoproteins in human tumor and nontumor cells and an estimation of its epitope structure.
Ohyama K; Uchide N; Suzuki R; Iwamoto N; Bessho T; Watanabe H; Hirakawa S; Yamakawa T
Cancer Detect Prev; 2000; 24(1):61-71. PubMed ID: 10757124
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the T antigen and T agglutinin in inbred rats.
Noeman SA; Misra DN; Gill TJ
Immunology; 1980 Feb; 39(2):219-29. PubMed ID: 6155326
[TBL] [Abstract][Full Text] [Related]
15. The integrin alpha 6 beta 4 on TA3/Ha mammary carcinoma cells is involved in adhesion to hepatocytes.
Kemperman H; Wijnands Y; de Rijk D; Roos E
Cancer Res; 1993 Aug; 53(15):3611-7. PubMed ID: 8339267
[TBL] [Abstract][Full Text] [Related]
16. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin.
Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM
Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638
[TBL] [Abstract][Full Text] [Related]
17. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
18. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.
Cayeux S; Richter G; Noffz G; Dörken B; Blankenstein T
J Immunol; 1997 Mar; 158(6):2834-41. PubMed ID: 9058819
[TBL] [Abstract][Full Text] [Related]
19. Viral aetiopathogenesis of tumors.
Klein E
Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986
[No Abstract] [Full Text] [Related]
20. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
